Aptar Pharma and Macquarie University partner on drug delivery project
Aptar and Macquarie's partnership will evaluate how factors, including how formulation variables influence drug delivery with Aptar’s dry powder inhaler…
Featured s
FDA clears Marani Health’s remote maternal monitoring system
Marani's M•wrap for foetal and and maternal heart signal monitoring is intended to give patients an at-home monitoring option versus…
All Articles
Aptar Pharma and Macquarie University partner on drug delivery project
Aptar and Macquarie's partnership will evaluate how factors, including how formulation variables influence drug delivery with Aptar’s dry powder inhaler…
FDA clears Marani Health’s remote maternal monitoring system
Marani's M•wrap for foetal and and maternal heart signal monitoring is intended to give patients an at-home monitoring option versus…
Revvity introduces GSP T1D 3plex kit for type 1 diabetes detection
GSP T1D 3plex kit uses capillary dried blood spot samples and is processed on Revvity’s GSP instrument.
FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics
The proposed prescription-only product would be separate from Glytec’s existing Glucommander technology.
Anaconda Biomed raises $56m for catheter portfolio’s advance
The funds will support Anaconda's clinical development aims and the completion of its pivotal IDE study.
Australia starts investigation into OpenAI Medicare breach
Amid this probe, experts point to the importance of airtight AI governance when implementing the technology in high-risk contexts.
FDA panel endorses GRAIL’s multi-cancer early detection test
The panel voted 7-2 vote in favour of GRAIL’S Galleri multi-cancer early detection (MCED) test’s benefits outweighing its risks.
Xella and ŌURA integrate for women’s health management
The integration is intended to connect changes detected by a wearable with information about possible biological factors.
Precision Diabetes and DirectSens to introduce MetMark test in US
DirectSens will supply the assay technology, product documentation and technical onboarding.
NET Recovery wins FDA breakthrough tag for psychostimulant addiction device
NET Recovery’s device applies neurostimulation to quell cravings in individuals with stimulant use disorder.